243 related articles for article (PubMed ID: 32705281)
1. Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom.
Kerslake R; Hall M; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Mol Med; 2020 Sep; 46(3):949-956. PubMed ID: 32705281
[TBL] [Abstract][Full Text] [Related]
2. Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19.
Katopodis P; Anikin V; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Oncol; 2020 Aug; 57(2):533-539. PubMed ID: 32468052
[TBL] [Abstract][Full Text] [Related]
3. COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.
Katopodis P; Kerslake R; Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Anikin V; Polychronis A; Robertus JL; Kyrou I; Karteris E
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649798
[TBL] [Abstract][Full Text] [Related]
4. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).
Katopodis P; Randeva HS; Spandidos DA; Saravi S; Kyrou I; Karteris E
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34935057
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation.
Tang Q; Wang Y; Ou L; Li J; Zheng K; Zhan H; Gu J; Zhou G; Xie S; Zhang J; Huang W; Wang S; Wang X
Int J Biol Sci; 2021; 17(8):1925-1939. PubMed ID: 34131396
[No Abstract] [Full Text] [Related]
6. Digestive system infection by SARS‑CoV‑2: Entry mechanism, clinical symptoms and expression of major receptors (Review).
Zheng L; Zhang L; Zheng Y; An J; Wen G; Jin H; Tuo B
Int J Mol Med; 2023 Mar; 51(3):. PubMed ID: 36660939
[TBL] [Abstract][Full Text] [Related]
7. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
[TBL] [Abstract][Full Text] [Related]
8. Evidence of SARS-CoV2 Entry Protein ACE2 in the Human Nose and Olfactory Bulb.
Klingenstein M; Klingenstein S; Neckel PH; Mack AF; Wagner AP; Kleger A; Liebau S; Milazzo A
Cells Tissues Organs; 2020; 209(4-6):155-164. PubMed ID: 33486479
[TBL] [Abstract][Full Text] [Related]
9. Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19.
Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Karteris E; Kyrou I
Mol Med Rep; 2020 Nov; 22(5):4221-4226. PubMed ID: 33000221
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
12. Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19.
Hoang T; Nguyen TQ; Tran TTA
Cancer Res Treat; 2021 Jul; 53(3):650-656. PubMed ID: 33421977
[TBL] [Abstract][Full Text] [Related]
13. Protein expression of transmembrane protease serine 4 in the gastrointestinal tract and in healthy, cancer, and SARS‑CoV‑2 infected lungs.
Kerslake R; Randeva HS; Jonigk D; Werlein C; Robertus JL; Katopodis P; Jasker P; Spandidos DA; Kyrou I; Karteris E
Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35211765
[TBL] [Abstract][Full Text] [Related]
14. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection.
Qi J; Zhou Y; Hua J; Zhang L; Bian J; Liu B; Zhao Z; Jin S
Int J Environ Res Public Health; 2021 Jan; 18(1):. PubMed ID: 33401657
[TBL] [Abstract][Full Text] [Related]
15. Gene expression analysis identifies genes associated with SARS-COV-2 receptors, ACE2 and TMPRSS2, in normal human lung tissues.
Hu RW; Liu C; Gong JP; Cao ZX
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2409-2414. PubMed ID: 33755980
[TBL] [Abstract][Full Text] [Related]
16. An investigation into the molecular basis of cancer comorbidities in coronavirus infection.
Facchiano A; Facchiano F; Facchiano A
FEBS Open Bio; 2020 Nov; 10(11):2363-2374. PubMed ID: 32970391
[TBL] [Abstract][Full Text] [Related]
17. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
[TBL] [Abstract][Full Text] [Related]
18. The Cellular basis of loss of smell in 2019-nCoV-infected individuals.
Gupta K; Mohanty SK; Mittal A; Kalra S; Kumar S; Mishra T; Ahuja J; Sengupta D; Ahuja G
Brief Bioinform; 2021 Mar; 22(2):873-881. PubMed ID: 32810867
[TBL] [Abstract][Full Text] [Related]
19. Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Alabed M; Tayoun AA; Loney T; Uddin M; Senok A; Al Heialy S; Hamoudi R; Kashour T; Alsheikh-Ali A; Hamid Q; Halwani R
Clin Transl Sci; 2020 Nov; 13(6):1048-1054. PubMed ID: 32799423
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.
Li HH; Liu CC; Hsu TW; Lin JH; Hsu JW; Li AF; Yeh YC; Hung SC; Hsu HS
Part Fibre Toxicol; 2021 Mar; 18(1):11. PubMed ID: 33706759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
